Orthopaedic manifestations of sickle-cell disease. by Huo, M. H. et al.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 63 (1990), 195-207
Orthopeedic Manifestations ofSickle-Cell Disease
MICHAEL H. HUO, M.D.,a GARY E. FRIEDLAENDER, M.D.,b AND
JAMES S. MARSH, M.D.C
aResident inOrthopaedic Surgery andRehabilitation, Yale UniversitySchool of
Medicine; bProfessor and Chairman, Department ofOrthopaedics and
Rehabilitation, Yale University School ofMedicine;cAssistant Professor,
Department ofOrthopedics andRehabilitation, Yale University Schoolof
Medicine, New Haven, Connecticut
Received January 12, 1990
Sickle-cell disease is a well-recognized clinical entity. The pathophysiology ofthis hemoglobin-
opathy has been described in detail by numerous investigators since the first case report appeared
in 1910. Orthopedic manifestations of sickle-cell disease account for much of the morbidity
associated with this disorder, including pain, osteonecrosis, arthritis, and sepsis. Effective
management of these bone and joint sequelae reflect accurate diagnosis, understanding of this
disorder's pathophysiology, and knowledge of available medical and surgical treatment alterna-
tives.
In this review, the authors summarize the major orthopedic manifestations of sickle-cell
disease with special emphasis placed upon osteonecrosis and osteomyelitis, since these conditions
are the most disabling and seriouscomplications in patients with sickle-cell disease.
INTRODUCTION
Prior to the first report in 1910 by Herrick ofan anemic black medical student from
Grenada, sickle-cell disease was misdiagnosed because itscardinal manifestations were
common tootherdisorders [1]. Repeatedjuxta-articularpainresembled acute rheuma-
tism. Jaundice and hemolysis were frequently seen in patients with malaria. Within
three months oftheoriginal report, a second caseofsickle-cell diseasewasdescribed by
Washburn, and during the next 30 to 40 years our understanding of this disease
considerably expanded [2].
Vaso-occlusive phenomena were appreciated in the early 1930s when infarcts ofthe
pulmonary and renal systems were discovered. Bone infarction and osteonecrosis ofthe
femoral head were described in the 1940s by Danford [3]. In 1949, Pauling and his
colleagues found that all the hemoglobin in patients with sickle-cell disease showed an
abnormal electrophoretic pattern [4]. This discovery was the most significant mile-
stone in understanding the pathogenesis and pathophysiology ofthis disease.
ETIOLOGY AND PATHOPHYSIOLOGY
There are few disorders of man whose etiology can be traced to as basic a level as
sickle cell disease. In 1957, Ingram elucidated the biochemical defect in sickle-cell
disease bydigesting hemoglobin with trypsin andstudying thepeptidesbyelectrophore-
sis and chromatography [5]. Sickle hemoglobin results from substitution of thymine
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for adenine in the glutamic acid codon ofDNA which, in turn, results in a substitution
ofvaline for glutamic acid in the beta-6 position ofthe hemoglobin molecule [6].
The hemoglobin molecule consists of four subunits, two alpha and two beta. The
interaction between these subunits i-s dependent upon forces such as hydrogen bonding
and covalent cross-linkages between the side chains ofthe amino acids in the subunits.
Hemoglobin molecules also exist in an oxygenated and a deoxygenated state. It has
been shown that deoxygenated hemoglobin S molecules have a high tendency to
aggregate.
Electron microscopy had shown that hemoglobin S molecules will aggregate into
microtubules. The exact nature of these microtubules has not been determined, but a
solid structure offourteen strands is the most widely accepted hypothesis [7]. Sickling
is initially reversible with correction of the adverse conditions that have precipitated
the event. When a cell sickles and unsickles repeatedly, however, its membrane is
permanently altered. These end-stage cells are primarily responsible for the clinical
manifestations seen in patients with sickle-cell disease [8]. Although the primary
defect in sickle-cell disease isclearly in the hemoglobin molecule, secondary alterations
in red cell metabolism and cell membrane structure and function also occur. For
example, ionicimbalanceandchanges in thesurfacecharges at thecell membrane may
contribute to the vaso-occlusive phenomenon in sickle-cell crisis [9].
DIAGNOSIS
The inheritance pattern of sickle-cell disease is autosomal recessive, and major
genotypes areSS (homozygous), SC (sickle-hemoglobin C), andsickle-betathalassemia
disease. The incidence ofsickle-cell trait (SA) has been estimated to be approximately
eight to ten percent among American blacks while the homozygous population is in the
range of0.2 to 0.5 percent ofthis same group. Sickle-cell trait may reach a 20 percent
incidence in Western Africa [10].
Diagnosis of the major genotypes of sickle-cell disease is relatively simple, but
differentiation ofthe various subtypes is more complex, requiring a variety ofsophisti-
cated laboratory procedures. The difference in migration patterns of normal and
hemoglobin S seen during electrophoresis is due to the two fewer negative charges
resulting from the substitution ofvaline for glutamic acid in the abnormal molecule.
BONE AND JOINT MANIFESTATIONS
Sickle-cell disease presents clinically as a multi-system disorder. One of the major
organ systems involved and one that has contributed to much of the morbidity is the
musculoskeletal system [ 1].
Bony changes seen in the sickle-cell disease can be grouped into two major types:
those due to bone marrow hyperplasia secondary to the profound and prolonged
anemia, and those changes due to ischemic necrosis ofbone and its complications. One
must also realize that the bony manifestations of sickle-cell disease are extremely
variable and represent a wide spectrum of changes. Different individuals will follow
different clinical courses, and, in any one person, the radiographic and pathological
manifestations change over time as well.
It is now recognized that thethinned bonycortices, diminution and coarsening ofthe
medullary trabeculae, and widened marrow cavities in the tubular bones of sickle-cell
patients are all manifestations of increased erythropoiesis secondary to anemia [12-
14]. This pattern is primarily seen in children. The demand for increased erythropoie-
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sis leads to an expanded marrow distribution within individual bones and a spread of
this activity to bones not normally occupied by productive marrow. In adults with
sickle-cell disease, red marrow continues to fill the medullary cavities of long bones.
This condition is in contrast to normal adults, where the active marrow is limited
mainly to the axial skeleton.
Microscopically, the bone marrow is hypercellular and contains little fat. All cell
lines are increased, including the erythrocytic, granulocytic, and megakaryocytic
systems. Red marrow may even extend into the Haversian and Volkmann canal
systems ofthe long bonecortices. This extension accounts for manyoftheradiographic
changes observed. Enlargement of the marrow-containing medullary canal can pro-
duce a squared metacarpal. In the skull, thediploic space is widened, and there may be
a loss of definition of the outer table and an hair-on-end appearance. This striking
radiographic finding is seen in approximately 5 percent ofpatients. A lossofthenormal
concave margin of the distal femur can result in the so-called flask-shaped deformity.
Nutrient foramina may be enlarged secondary to the hyperdynamic circulation,
extreme cortical thinning may lead to spontaneous pathologic fractures, and acetabuli
protrusio may be present in some older patients [13-15].
Marrow expansion in the vertebrae leads to a characteristic radiolucency and
prominence of the remaining vertical trabeculae. Smooth biconcave and step-like
depressions are seen in thevertebral bodies, which areoften flattened with an increased
width-to-height ratio and an apparent enlargement of the pedicles. Some have attrib-
uted vertebral body deformities to weight bearing on osteoporotic and infarcted bones
[16] (Fig. 1). Sections of the vertebrae, however, do not show any evidence of
infarction. An alternative theory oflimited growth ofthe central area due to impaired
nutrient artery flow caused by marrow expansion in conjunction with normal growth of
the vertebral margins supplied by the metaphyseal arteries seems a more plausible
explanation. These vertebral changes have been reported in patients as young as nine
months of age, and in most series reached a 40 percent incidence in older patients
[16-18].
Changes reflecting bone marrow hyperplasia are usually asymptomatic and can be
seen in other forms of anemia as well as sickle-cell disease. Chronic anemia causes
alterations in bone marrow distribution and a distorted bony architecture secondary to
marrow hyperplasia. Although these changes are not directly related to the develop-
ment of ischemic osteonecrosis, they probably play a role in determining the sites,
distribution, and late bone changes observed following medullary and cortical infarcts.
Infarction
Any portion of a long bone can be the site of ischemic infarction, and several
locations in the same bone may be involved at the same time (Fig. 2). Some knowledge
of bone circulatory dynamics is important in understanding the pathogenesis and
healing ofbone infarcts and the different manifestations ofbone ischemia that occur at
different ages and in various portions ofthe bone [19,20].
Most authors agree that there are four important sources of blood supply to the
tubular bones: (1) Nutrient arteries supplythemedullary bone and the endosteal aspect
of the cortex. (2) Periosteal vessels perforate the cortex throughout its length and
circumference supplying the outer cortex. (3) Metaphyseal perforators are branches of
the periosteal system; they supply the peripheral portion of the metaphysis and the
growth plate. (4) The epiphyseal arteries supply the epiphysis.
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FIG. 1. Biconcave depressions of the vertebral
bodies in sickle-cell disease.
Each long bone can be divided into five sections: a large central segment, two small
metaphyseal segments, and two meta-diaphyseal or intermediate zones. The most
common sites ofacute infarcts in sickle-cell patients are at the intermediate segments.
Potential circulation to the cortex is the greatest at the metaphysis. It has been
demonstrated that the periosteal blood flow can be reversed in the case of nutrient
artery interruption; this procedure may protect the diaphyseal cortex from infarcts. In
the intermediate zone, collateral circulation from the perforating metaphyseal vessels
may be either insufficient or compromised in sicklers, thus leading to infarction.
Localized infarcts occur primarily in younger children in whom the periosteal source of
collateralization has not yet become well developed [16,17,21].
Clinically, lesions ofacute infarction present with acutelocalized pain, swelling, and
fever. Children younger than age eight to ten years often develop acute dia-
metaphyseal infarcts associated with marked pain and swelling. A more gradual and
often asymptomatic marrow ischemia and necrosis occurs in older age groups. In a
review of 198 diaphyseal infarcts in 81 Nigerian patients, Bohrer reported that 91
percent ofthe lesions occurred before age nine. The tibia was the most common site of
involvement, and bilateral infarcts were noted in 23 percent of the cases [16,22].
Malignant transformation of the infarcts to, most typically, malignant fibrohistiocy-
toma, is possible but only rarely reported in sickle-cell disease.
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11 U FIG. 2. Multiple infarcts involving the femur and the tibia.
Painful Crisis
Painful crisis is one of the most characteristic manifestations of sickle-cell disease
and consists ofpain in the extremities, back, chest, or abdomen. It is usually associated
with a febrile episode, making distinction from acute infection difficult. Acute bony
infarction is usually seen in the meta-diaphyseal region, and multiple sites are
commonly involved. Juxta-articular areas are especially vulnerable and accompanied
byjoint effusion. The pain is usually bilateral and sometimes migratory when extremi-
ties are involved [11,16,22].
Painful crises usually start at five years ofage and progress in various unpredictable
patterns until after age thirty. Precipitating factors include: infection, cold tempera-
ture, acidosis, pregnancy, hypoxia, and dehydration [23]. Necrotic marrow material,
such as fat globules and even spicules of bone, may embolize to small vessels in the
brain, lungs, orkidneys [24]. The increased marrow pressure from marrow hyperplasia
and the acute-phase reaction to infarction may predispose that site to subsequent
hematogenous infection.
Hand-Foot Syndrome
A well-known clinical entity seen in sickle-cell disease patients is dactylitis, also
known as hand-foot syndrome. Thissyndrome wasoriginallydescribed by Danford and
subsequently characterized by Smith [25]. In an earlier review by Watson et al.
(1963), 66 percent ofthe cases reported in the series of 52 patients were younger than
two years ofage [26]. Estimates oftheprevalence ofthis condition havevaried from 11
percent to as high as 80 percent in the African population. Stevens in a recent study
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from Jamaica reported an incidence of 8 percent by the age of six months, 24 percent
by one year, and 45 percent by two years [27]. This early age of involvement implies
that dactylitis may often be the presenting symptom ofpatients with sickle-cell disease.
The pathophysiology again reflects ischemic infarction. As previously mentioned,
active marrow is present in the small bones of the hands and feet in young children.
Clinically, the child presents with acute non-pitting edema of one or more extremities
that is usually painful and associated with fever. Pain and swelling usually resolve in
one week; however, recurrences are frequent. Radiographs are initially normal, but
consistent with infarction and periosteal new bone formation becomes apparent by the
second week. The differential diagnosis in a child presenting with dactylitis must
include osteomyelitis, leukemia, and other forms of inflammatory and infectious
disorders.
Osteonecrosis ofthe Femoral Head
Ischemic necrosis of the proximal femur in sickle-cell disease has been diagnosed as
early as six years of age. Its reported incidence ranges from 15 percent to 30 percent,
and some report a higher prevalence in patients with hemoglobin SC disease than
hemoglobin SS disease. Sebes, in 1983, reported a similar incidence for both patient
populations [28,29].
The vascular anatomy of the femoral head is complex and changes with age, as well
characterized by Trueta. After the age ofthree or four years, the growth plate acts as a
barrier to the metaphyseal vessels. Sufficient perfusion is initiated through the ligamen-
tum teres by the age of eight to ten [30]. Following fusion of the physis, circulation
through the metaphyseal system is re-established. Most of the patients with sickle-cell
disease present with changes of osteonecrosis after the age of twelve. This condition
corresponds to a stage of multiple sources of blood supply to the femoral head, in
contrast to patients with Legg-Calve-Perthes disease.
Clinical features are no different from avascular necrosis secondary to other causes.
Pain on weight bearing is the primary presenting symptom. Sebes, however, reported
nearly 50 percent of his patients with this disorder were asymptomatic [29]. Outcome
is dependent upon the age of involvement. Necrosis of the immature epiphysis leading
to a flattening of the femoral head with corresponding remodeling of the acetabulum
can often result in maintenance of near normal range of motion and a relatively
asymptomatic course for long duration. This concept of a congruous incongruity has
been well described in association with Legg-Calve-Perthes disease. Involvement ofthe
mature femoral head often leads to segmental collapse, resulting in persistent pain and
progressive degeneration of the hipjoint [31].
Early diagnosis of avascular changes can be achieved with comparative marrow
technetium sulfur colloid scan and technetium pyrophosphate bone scan. Both tech-
niques demonstrate low activity following acute infarction. Later, however, the marrow
scan will remain cold while the bone scan will have increased activity secondary to the
reparative phase. These changes are usually evident on scan before plain radiographic
findings become apparent. Magnetic resonance imaging techniques are currently the
most sensitive and recommended diagnostic modality for this disorder [32,33].
Surgical treatment for this condition ranges from myotomy of the adductors,
osteotomy of both the femur and acetabulum, arthrodesis, to various forms of arthro-
plasties [28] (Figs. 3, 4). Most of these approaches have met with poor success.
Arthrodesis is especially inappropriate due to the high incidence of bilateral involve-
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FIG. 3. End-stage os-
teonecrosis ofboth femo-
ral heads.
ment. Cup arthroplasty has also been disappointing. Gunderson, in 1977, reported the
results of 11 total hip replacements in seven patients who had hemoglobin SS disease
[34]. Complication included two femoral fractures and oneinfection. Epps and Castro,
in 1978, reported complications in 24 of41 hip arthroplasties performed in 30 patients
with hemoglobinopathies [35]. Sebes and Kraus, in 1983, reported uniform failure in
patients who underwent a hemiarthroplasty [29]. Most recently, Hanker et al. and
Bishop et al. reported poor results in their respective series. Hanker and Amstutz
reported a projected revision rate of 50 percent within 5.4 years from a primary
arthroplasty using the Kaplan-Meir survivorship analysis method [36]. This result is in
dramatic contrast to the reported revision rate of 10-15 percent for age-matched
patients with idiopathic avascular necrosis ofthe femoral head. In Bishop's series, four
out of 11 had an infection, while four required a revision and three required a resection
arthroplasty [37]. Both articles also emphasized the presence of multiple technical
difficulties due to the underlying medical problems and poor quality ofbone stock.
Avascular necrosis can affect other bones as well. Humeral head involvement has
been reported to have an incidence of 2-17 percent and is often seen with avascular
w; * B | * l I ~~~~~..
.........
FIG. 4. Reconstruc
tion with bilateral ce-
mentless total hip
arthroplasties.
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FIG. 5. Osteonecrosis of the humeral head l, E E .!. ..|- and ischemic infarction ofthe humeral shaft.
changes in the hipjoint [38] (Fig. 5). Tarsal bones, ribs, skull, and mandible have all
been described in sites ofinvolvement.
Osteomyelitis
Hodges and Holt, in 1951, first recognized an association between sickle-cell disease
and salmonella osteomyelitis [39]. Since then salmonella infections have become a
major subject ofstudy for those interested in sickle-cell disease [40-51].
Salmonella is an uncommon cause of osteomyelitis in the general population.
Hughes and Carrol, in 1957, reported four cases in over 100 reviewed [47]; they were
all in sicklers. Hook estimated that diagnosis of hemoglobin SS disease occurred 70
times more frequently than expected in patients with salmonella infections [46].
Barrett-Connor had calculated a 25-fold increase in the risk ofdeveloping salmonella
infection in sickle-cell disease [42]. Engh et al. reported a 29 percent incidence of
hemoglobinopathies among 142 cases reviewed in the orthopedic literature [45]. In a
comprehensive review of osteomyelitis in New York City, in 1978, Ortiz-Neu et al.
identified 37 cases ofsalmonella osteomyelitis. Fourteen ofthesepatients had hemoglo-
binopathy [49]. In a recent report fromNigeria of63 casesofsalmonella osteomyelitis,
57 patients had sickle-cell disease [40]. Ebong described four cases ofbilateral massive
pelvic osteomyelitis [43]. Two ofthese patients had salmonella as the causative agent,
and both had sickle-cell disease. More recently, Mallough reviewed 12 cases of bony
infections in sickle-cell patients in Saudi Arabia and found that 83 percent of these
were caused by salmonella [48].
Despite the above-mentioned experience, staphylococcal infections are still the most
common bony infections seen in sickle-cell patients. The major organism recovered in
21 consecutivepatients with sickle-cell diseaseover a 24-month period wasstaphylococ-
cus [50].
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The prompt and accurate diagnosis of osteomyelitis in patients with sickle-cell
disease is essential. The signs of bone pain, fever, and local swelling may very well
represent either bone infarction or osteomyelitis. Laboratory parameters and plain
radiographs are often nonspecific and cannot reliably differentiate the two [41,52-56].
Though bone infarction is much more frequent than osteomyelitis in sickle-cell disease,
a high level of suspicion and judicious use of clinical parameters assisted by scinti-
graphic evidence are crucial to establish an early diagnosis of deep infection in these
patients.
The mechanism of the noted susceptibility to salmonella is unclear. It is postulated
that this organism enters the circulation through microinfarcts in the intestinal
mucosa. Immunological studies in sicklers have demonstrated near normal cell-
mediated responses and immunoglobulin levels; however, complement-mediated op-
sonization is decreased in these individuals. The previously infarcted and now necrotic
bony segments are probably more susceptible to a septic episode [42,51,57].
In the past, treatment has been centered on identification of the subtype of
salmonella, and administering an appropriate combined intravenous antibiotic regi-
men for six weeks. The usual therapeutic approach consists of ampicillin and a
cephalosporin. There is some early evidence that ciprofloxacin may be the drug of
choice in eradicating even the carrier state in these patients.
Septic Arthritis
Septic arthritis in patients with hemoglobin SS disease is uncommon. Barrett-
Connor described 250 infections in 166 sickle-cell patients and found only two cases of
septic arthritis [42]. Nelson reported only four cases ofjoint infection among 289 cases
of arthritis over a 19-year period [58]. Ebong described nine patients with septic
arthritis; they all had concurrent osteomyelitis. The septic joint, however, did not
necessarily occur next to the site of active bony infection. Salmonella arthropathy is
very rare, as was pointed out by David and Black in a comprehensive review of84 cases
ofsalmonellajoint infections over 64 years, only one ofwhich was seen in a sickle-cell
patient [59].
The prognosis for sickle-cell disease patients with septic arthritis is guarded at best.
In the small numberofcases discussed by Ebong, only 30 percent ofthejoints involved
resolved in less than three months [44]. Early aggressive drainage, debridement, and
splintage as with joint infections in other patients are crucial. A two-week course of
intravenous antibiotic therapy in joint infection without concomitant osteomyelitis is
usually sufficient. In addition to orthopedic management, it is essential to maximize
the patient's general medical condition with hydration, oxygenation, and nutrition in
order to minimize other complications.
Otherjoint manifestations of sickle-cell disease include a sterile arthritis occurring
during painful crisis [60]. These events may be attributed to adjacent infarcts in the
patella or in the synovium. A migratory polyarthralgia along with a cardiac murmur is
sometimes present during painful crisis and has been mistaken for rheumatic fever.
The increased purine turnover of accelerated erythropoiesis results in a greater
production ofuric acid [61]. In younger patients with sickle-cell disease, plasma levels
of uric acid are balanced by increased renal clearance. With aging and renal damage,
urate levels may rise significantly, but frank gouty arthritis is uncommon in sickle-cell
disease. One should, however, be aware ofthis potential complication.
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Risk in Anesthesia andSurgery
Sickle-cell trait is associated with a very low complication rate with general
anesthesia. Sickle-cell disease, on the other hand, does constitute a significantly
increased risk for anesthesia and surgical procedures.
Goals in management ofanesthesia include avoidance ofacidosis due tohypoventila-
tion, prevention of circulatory stasis due to improper positioning or hypovolemia, and
maintenance of temperature regulation. The role of exchange transfusion to decrease
the percentage of sickled erythrocytes has long been debated. For major procedures
such as total hip arthroplasty, however, it should be a routine pre-operative measure.
Tourniquets create a static reservoir ofblood which must inevitably undergo sickling
and removal of the tourniquet would release a bolus of the sickled cells into the
circulation. Stein and Urbaniak, however, reviewed two groups of patients over a
period of 15 years; 21 cases of sickle-cell patients were compared to 50 controls; they
concluded there was no increased rate of complications with the use of a tourniquet
during the surgical procedure [62].
Radiographic contrast medium used in studies such as arteriography or pyelograms
can change the serum viscosity, and this change may lead to a sickling crisis. It is
important for the treating physician to appreciate these special situations and their
potential complications. Appropriate measures must be undertaken in order to mini-
mize morbidity posed to these patients, such as those approaches described above for
anesthetic management.
Bony Changes in Sickle-Cell Variants
Patients with sickle-hemoglobin C disease have the same radiographic changes and
similar clinical risks for infarcts and infections as patients with homozygous SS
disease. Some authors have reported a higher incidence of osteonecrosis in patients
with SC disease than in SS disease [12]. Sebes and Kraus, however, did not find any
increase in avascular necrosis affecting the femoral head in their review [29]. Patients
with sickle-thalassemia also develop the same characteristic changes as those observed
in individuals with hemoglobin SS disease. The severity and frequency of these
findings, however, are generally less in sickle-thalassemia due to the higher levels of
normal hemoglobin molecules in these patients. Patients with heterozygous sickle-cell
trait usually have sufficient amounts of hemoglobin A to preclude hypoxic episodes
under physiologic conditions. They can develop the characteristic changes seen in SC
and SS disease patients when subjected to hypoxemia. In a recent report on total hip
arthroplasties for end-stage osteonecrosis in patients with sickle-cell disease, 20
percent had sickle-cell trait [63].
CONCLUSION
In summary, sickle-cell disease is a multi-system disorder. Musculoskeletal involve-
ment accounts for much of the morbidity suffered by these patients. The principal
radiographic changes seen in bone are secondary to marrow hyperplasia and ischemic
osteonecrosis as well as thecomplications ofboth these processes. It remains difficult to
differentiate vaso-occlusive crises ofsickling from acute infections ofthe musculoskel-
etal system, but the use of isotope scans and magnetic resonance imaging are useful
adjuncts to obtaining an accurate diagnosis. Joint infections are extremely uncommon
in sickle-cell disease. If there is concomitant osteomyelitis, however, a high degree of
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suspicion for acute septic arthritis is appropriate. Aggressive management of painful
crisis and maintenance of a stress-free environment must be undertaken to minimize
morbidity to these patients. Reconstructive surgical procedures for bone and joint
destruction offer, at best, a fair prognosis for patients affected with sickle-cell disease.
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